EAN 2026: New Fintepla Data in Dravet Syndrome and LGS
The recent trial data presented at EAN 2026 highlights the efficacy of Fintepla in treating…
Newswire
Lilly and Regeneron Among First Incumbents to FDA’s Fast-Track Facility Scheme
Seven pharmaceutical companies, including Eli Lilly and Regeneron, have been selected for the FDA’s PreCheck…
Viridian may have edge over Amgen in eye drug showdown, analysts argue
The FDA has granted a new approval for Viridian’s drug, which analysts suggest could provide…
Top FDA gene and cell therapy regulator to step down
Vijay Kumar, a prominent figure in the FDA’s gene and cell therapy division, is set…
Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
Amgen’s rare disease treatment, Tavneos, faces a significant setback following the retraction of its pivotal…
AstraZeneca to Pay $34 Million to Settle Kickback Allegations in Texas
AstraZeneca has agreed to pay $34 million to settle a lawsuit alleging that the company…
Beeline Secures Over $426 Million in Series A Funding for Immune Drug Development
Beeline has successfully extended its Series A funding round, amassing over $426 million to further…
All of Us Program Leverages Patient Data-Sharing Networks to Enhance Real-World Data Collection
A boundary-pushing federal health research program has secured thousands of electronic medical records as it…
Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32
Flamingo Pharma UK Ltd has issued a Class 3 medicines recall for specific packs of…
Relonchem Limited Issues Class 4 Medicines Defect Notification for Gabapentin Oral Solution
Relonchem Limited has notified the Medicines and Healthcare products Regulatory Agency (MHRA) of a Class…